Novo CEO pressed by Senate to chop rates of being overweight, diabetes medicine CEO Lars Fruergaard Jørgensen told lawmakers the company would look at new talks with insurers with regards to the listing price ranges of Wegovy and copyright if they pledge to help keep the medicines on their formularies. https://kethek.com/